Leishmaniasis and autoimmune diseases in pediatric age

Area of Science:

• Parasitology
• Immunology
• Tropical Medicine

Background:

• Leishmaniasis encompasses diseases caused by Leishmania protozoa, prevalent in Mediterranean regions.
• It presents as cutaneous, mucosal, or visceral leishmaniasis, with the visceral form being potentially lethal.
• The complex immunology and pathogenesis of Leishmania infections are not fully understood.

Purpose of the Study:

• To highlight the diagnostic challenges of visceral leishmaniasis.
• To emphasize the importance of considering leishmaniasis in differential diagnoses, especially for autoimmune-like presentations.
• To underscore the risks associated with misdiagnosis and inappropriate immunosuppressive treatment, particularly in pediatric cases.

Main Methods:

• Review of clinical manifestations and diagnostic standards for visceral leishmaniasis.
• Comparison of leishmaniasis symptoms with autoimmune diseases (e.g., lupus erythematosus, autoimmune hepatitis).
• Emphasis on diagnostic vigilance in pediatric patients.

Main Results:

• Visceral leishmaniasis can be misdiagnosed as autoimmune diseases due to overlapping symptoms.
• The gold standard for visceral leishmaniasis diagnosis involves detecting amastigotes in bone marrow or tissue.
• Pediatric patients face a high risk of life-threatening complications if diagnosis is delayed.

Conclusions:

• Clinicians must maintain a high index of suspicion for leishmaniasis, particularly when symptoms mimic autoimmune conditions.
• Accurate and timely diagnosis is essential to avoid incorrect immunosuppressive therapy.
• Awareness of leishmaniasis is critical for effective patient management and improved outcomes.